| May 31, 2012 | May 31, 2013 | May 31, 2014 | May 31, 2015 | May 31, 2016 | May 31, 2017 | Mar 30, 2019 | Mar 28, 2020 | Apr 3, 2021 | Apr 2, 2022 | Apr 1, 2023 |
---|
Net income | - | - | - | - | - | - | -58 | 58 | 85 | 248 | 402 |
---|
Depreciation and amortization | - | - | - | - | - | - | 16 | 19 | 18 | 21 | 27 |
---|
Equity-based compensation | - | - | - | - | 0 | 0 | 102 | 8 | 6 | 10 | 14 |
---|
Deferred taxes | - | - | - | - | - | - | - | - | - | - | -1 |
---|
Amortization of Debt Issuance Costs | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
---|
(Gain) loss on disposal of property, plant, and equipment | 3 | 2 | 1 | 0 | - | 1 | 0 | -0 | 0 | -1 | 0 |
---|
Foreign currency transaction loss (gain) | - | - | - | - | - | - | -0 | -0 | 1 | 0 | -1 |
---|
Accounts receivable | -0 | 2 | 8 | -5 | -0 | -2 | 2 | -12 | 9 | 33 | -23 |
---|
Inventories | -0 | 0 | 3 | -1 | 2 | 1 | 6 | 4 | 31 | 75 | -49 |
---|
Other assets | -1 | -0 | 0 | -0 | -0 | 0 | 2 | 11 | -1 | 28 | 12 |
---|
Accounts payable | - | - | - | - | - | - | -3 | -5 | 16 | 35 | -49 |
---|
Accrued expenses and other current liabilities | - | - | - | - | - | - | - | - | 65 | 43 | -40 |
---|
Net cash provided by operating activities | -19 | -14 | -18 | -4 | 4 | 3 | 65 | 77 | 154 | 224 | 416 |
---|
Additions to property, plant, and equipment | 1 | 0 | 1 | 0 | 1 | 1 | 12 | 15 | 8 | 32 | 52 |
---|
Cash paid for acquisitions, net of cash acquired | - | - | - | - | - | - | -10 | - | 53 | 0 | 7 |
---|
Cash paid for equity method investment | - | - | - | - | - | - | - | - | - | - | 3 |
---|
Proceeds from Life Insurance Policy | - | - | - | - | - | - | - | - | 2 | - | - |
---|
Proceeds from Sale of Property, Plant, and Equipment | 5 | 1 | 2 | 2 | - | 2 | 0 | 0 | 2 | 0 | 0 |
---|
Net cash used in investing activities | 22 | 14 | 5 | 6 | -1 | 1 | -2 | -14 | -57 | -32 | -61 |
---|
Changes in floor plan financing, net | - | - | - | - | - | - | 3 | 1 | -8 | 10 | -35 |
---|
Payments on revolving debt facility | - | - | - | - | - | - | 5 | 15 | 38 | 27 | - |
---|
Payments for deferred financing fees | - | - | - | - | - | - | 2 | - | - | 1 | - |
---|
Stock option exercises | - | - | - | - | - | - | 2 | 0 | 0 | 1 | 2 |
---|
Tax payments for equity-based compensation | - | - | - | - | - | - | 5 | 2 | 2 | 3 | 4 |
---|
Net cash used in financing activities | -2 | - | 6 | -2 | - | - | -73 | 22 | -48 | -20 | -37 |
---|
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | - | - | - | - | - | - | -1 | -1 | 4 | 0 | -6 |
---|
Net increase in cash, cash equivalents, and restricted cash | - | - | - | - | - | - | -10 | 83 | 53 | 173 | 312 |
---|
Cash paid for interest | - | - | - | - | - | - | 5 | 4 | 4 | 3 | 3 |
---|
Income Taxes Paid, Net | - | - | - | - | - | - | 14 | 22 | 18 | 74 | 144 |
---|